SYNGEN BIOTECH CO.,LTD BUILDING A. NO

Company Introduction:

Syngen Biotech Co., Ltd. is a biopharmaceutical company based in Taiwan. The company is dedicated to the research, development, manufacturing, and commercialization of innovative new drugs, with a primary focus on oncology and addressing unmet medical needs. Syngen Biotech leverages advanced biotechnological platforms for drug discovery, conducts rigorous preclinical and clinical trials, and is committed to bringing novel therapeutic solutions to patients worldwide.

Business Type:

Syngen Biotech Co., Ltd. is primarily a factory (manufacturer). They operate GMP-certified manufacturing facilities for the production of their pharmaceutical products, alongside extensive research and development activities. They are not a trading company.

SYNGEN BIOTECH CO.,LTD manufactures or sells the following products:

Medical Devices:

SYNGEL Post-Operative Adhesion Barrier

SYNGEL Medical Device for Oral Mucosa Repair

SYNGEL Medical Device for Nasal Mucosa Repair

SYNGEL Medical Device for Gynecological Repair

SYNGEL Medical Device for Orthopedic Repair

SYNGEL Medical Device for Nerve Repair

Pharmaceutical Products (in pipeline development):

SY001 (Pegfilgrastim Biosimilar) for chemotherapy-induced neutropenia

SY002 (Bevacizumab Biosimilar) for various cancers

SY003 (Adalimumab Biosimilar) for autoimmune diseases

SYL001 (Small Molecule Drug) for oncology

SYL002 (Small Molecule Drug) for oncology

Biotech Raw Materials:

Recombinant Human Serum Albumin (rHSA)

Recombinant Human Insulin (rHI)

Recombinant Human Growth Hormone (rHGH)

Recombinant Human Epidermal Growth Factor (rhEGF)

Recombinant Human Basic Fibroblast Growth Factor (rhbFGF)